UNICA IRIS Institutional Research Information System

DEFAZIO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 173.204
NA - Nord America 14.085
AS - Asia 5.725
SA - Sud America 1.769
AF - Africa 141
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 3
Totale 194.949
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 170.470
US - Stati Uniti d'America 13.780
SG - Singapore 2.637
CN - Cina 1.661
BR - Brasile 1.439
VN - Vietnam 665
SE - Svezia 649
UA - Ucraina 408
DE - Germania 388
GB - Regno Unito 312
FI - Finlandia 248
CA - Canada 183
FR - Francia 163
AR - Argentina 145
NL - Olanda 137
IN - India 110
TR - Turchia 99
KR - Corea 90
MX - Messico 74
AT - Austria 67
JP - Giappone 61
EC - Ecuador 60
RU - Federazione Russa 58
ID - Indonesia 57
HK - Hong Kong 56
BD - Bangladesh 47
ZA - Sudafrica 45
ES - Italia 43
PL - Polonia 40
IQ - Iraq 39
CO - Colombia 32
CH - Svizzera 29
IR - Iran 26
RO - Romania 26
EG - Egitto 23
IE - Irlanda 23
MA - Marocco 23
PY - Paraguay 22
CL - Cile 21
AE - Emirati Arabi Uniti 19
BE - Belgio 19
CZ - Repubblica Ceca 18
SA - Arabia Saudita 18
AL - Albania 17
PE - Perù 17
VE - Venezuela 17
IL - Israele 16
PK - Pakistan 16
TW - Taiwan 15
UZ - Uzbekistan 15
GR - Grecia 13
PH - Filippine 13
AU - Australia 11
NZ - Nuova Zelanda 11
DO - Repubblica Dominicana 10
JM - Giamaica 10
KE - Kenya 10
MY - Malesia 10
PT - Portogallo 10
BG - Bulgaria 8
JO - Giordania 8
RS - Serbia 8
UY - Uruguay 8
AZ - Azerbaigian 7
HU - Ungheria 7
LT - Lituania 7
NG - Nigeria 7
NP - Nepal 7
BO - Bolivia 6
CR - Costa Rica 6
DZ - Algeria 6
GH - Ghana 6
KZ - Kazakistan 6
MG - Madagascar 5
TN - Tunisia 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
EE - Estonia 4
GT - Guatemala 4
HR - Croazia 4
KG - Kirghizistan 4
LV - Lettonia 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
TH - Thailandia 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
ET - Etiopia 3
HN - Honduras 3
TT - Trinidad e Tobago 3
AO - Angola 2
BZ - Belize 2
IS - Islanda 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
Totale 194.926
Salva come PNG Salva come JPEG
Città #
Cagliari 160.405
Uta 5.701
Fairfield 2.306
Ashburn 1.355
Woodbridge 982
Seattle 894
Singapore 887
Houston 814
Boardman 810
Wilmington 753
Dallas 746
Cambridge 740
Nyköping 496
Ann Arbor 444
Beijing 410
Milan 372
Rome 367
Chandler 321
Helsinki 224
Boston 217
Los Angeles 217
Ho Chi Minh City 216
Jacksonville 209
Shanghai 200
New York 199
Nanjing 164
The Dalles 161
Buffalo 145
Hanoi 144
Guangzhou 138
São Paulo 138
Santa Clara 134
Munich 125
San Diego 121
Dearborn 111
Toronto 108
Naples 99
Redwood City 79
Turin 79
London 77
Bologna 70
Catania 69
Florence 64
Millbury 63
Norwalk 57
Dong Ket 56
Shenyang 56
Trabzon 56
Bari 54
Augusta 53
Seoul 53
Changsha 50
Hefei 50
Nuremberg 48
Tianjin 48
Chicago 45
Hong Kong 43
Verona 43
Rio de Janeiro 41
Jiaxing 40
Palermo 40
Hebei 39
Redondo Beach 38
Nanchang 36
Frankfurt am Main 35
Tokyo 35
Vienna 33
Padova 32
Curitiba 31
San Mateo 31
Brasília 30
Genoa 30
Belo Horizonte 28
Haiphong 27
Da Nang 26
Mountain View 26
Atlanta 25
Guayaquil 24
Sassari 24
Düsseldorf 23
Parma 23
Wuhan 23
Brooklyn 22
Montreal 22
Pescara 22
Chennai 21
Denver 21
Orange 21
Phoenix 21
Perugia 20
Salvador 20
Biên Hòa 19
Brescia 19
Fortaleza 19
Stockholm 19
Thái Bình 19
Mexico City 18
Johannesburg 17
Messina 17
Moscow 17
Totale 184.180
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson's disease 24.321
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with Parkinson’s disease 4.425
Neurosifilide e stroke ischemico: case report. 3.585
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding 3.302
Olfactory function and apathy as potential biomarker in patients with Parkinson's disease 3.004
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 2.715
Gender differences in olfactory function in patients with Parkinson's disease. 2.446
Epilessia mioclonica progressiva o epilessia parziale continua? 2.422
Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson's disease 2.353
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease 2.301
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.301
Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson's Disease 2.233
Sleep cardiac dysautonomia and EEG oscillations in Amyotrophic Lateral Sclerosis 2.225
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD) 2.160
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Idiopathic Parkinson's disease 2.130
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson's Disease (PDRBD) 2.099
Gender differences in olfactory dysfunctions in Sardinian patients affected by Parkinson’s disease 2.085
CORRELATION AMONG OLFACTORY DYSFUNCTION, APATHY AND FATIGUE IN PATIENTS WITH PARKINSON’S DISEASE 2.057
Upper limb movements in dementia with Lewy body: a quantitative analysis 1.952
Sensory trick in upper limb dystonia 1.945
Pulvinar sign in a case of anti-CV2 encephalitis 1.883
A “Catastrophic” Heparin-Induced Thrombocytopenia 1.859
Association between dopaminergic medications and REM sleep behavior disorder in Parkinson’s disease: a preliminary cohort study 1.734
NCSE: un caso di steroid-responsive encephalopathy associated with autoimmune thyroiditis 1.677
Genetic Creutzfeldt-Jakob disease in Sardinia: a case series linked to the PRNP R208H mutation due to a single founder effect 1.640
Prevalence of Huntington's disease in Southern Sardinia, Italy 1.606
Geographic differences in the incidence of Huntington's disease in Sardinia, Italy 1.561
Internal carotid artery dissection causing ischemic stroke during pole sport practice 1.542
Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia 1.539
Impact of supporting people with advanced Parkinson’s disease on carer’s quality of life and burden 1.538
Carotid plaque imaging profiling in subjects with risk factors (diabetes and hypertension) 1.494
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 1.411
The Relationships Between Ataxia and Cognition in Spinocerebellar Ataxia Type 2 1.387
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? 1.285
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 1.261
Does the network model fits neurophysiological abnormalities in blepharospasm? 1.207
Cerebellar Syndrome Associated with Thyroid Disorders 1.205
Serum anti-thyroid antibodies in Hashimoto’s encephalopathy: A never-ending story 1.200
Idiopathic Non-Task-Specific Upper Limb Dystonia, a Neglected Form of Dystonia 1.150
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia 1.147
Cannabinoids and dystonia: an issue yet to be defined 1.143
Advances in the pathophysiology of adult-onset focal dystonias: recent neurophysiological and neuroimaging evidence. 1.122
Functional neurological disorder after COVID-19 vaccination 1.064
Movement disorders phenomenology in focal motor seizures 1.062
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 1.037
Cognitive and Behavioral features of isolated Rem Sleep Bhaviour disorders (IRBD) and RBD associated with Parkinson's disease (PDRBD 1.025
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest? 979
The role of sensory information in the pathophysiology of focal dystonias 944
Status epilepticus in Hashimoto's encephalopathy 939
Neurophysiological features of REM sleep Behaviour Disorder (RBD) correlate with cognitive and psycho-behavioral profile 936
Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's disease 934
Effects of White Matter Hyperintensities on Brain Connectivity and Hippocampal Volume in Healthy Subjects According to Their Localization 916
Therapeutic Use of Cerebellar Intermittent Theta Burst Stimulation (iTBS) in a Sardinian Family Affected by Spinocerebellar Ataxia 38 (SCA 38) 912
Qualitative smell/taste disorders as sequelae of acute COVID-19 864
Diagnostic criteria for blepharospasm: A multicenter international study 862
Persistent myoclonic jerks: a case of epilepsia partialis continua or myoclonic progressive epilepsy? 850
Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm 846
Disease progression in blepharospasm: a 5-year longitudinal study 845
Reshaping cortical connectivity in traumatic spinal cord injury: a novel effect of hyperbaric oxygen therapy 844
Risk factors of Parkinson disease. Simultaneous assessment, interactions, and etiologic subtypes 842
Effetti della stimolazione del nervo vago sulle componenti aperiodiche dell’EEG in soggetti affetti da epilessia resistente ai farmaci 836
Frequency and Determinants of Olfactory Hallucinations in Parkinson’s Disease Patients 832
Olfactory impairment in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype: a pilot study 807
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease 795
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease 783
Is Adult-Onset Dystonia a Rare Disease? Time for Population-Based Studies 760
Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson’s Disease? A Systematic Review of the Current Literature 758
Pain in Parkinson's disease: facts and uncertainties 738
Neuroimaging in idiopathic adult-onset focal dystonia 713
Validation of a guideline to reduce variability in diagnosing cervical dystonia 698
Rasagiline withdrawal Syndrome in Parkinson’s Disease 698
23. Effects of vagal nerve stimulation on EEG aperiodic parameters in subjects affected by drug-resistant epilepsy 697
Olfactory Impairment Correlates with Executive Functions Disorders and Other Specific Cognitive Dysfunctions in Parkinson’s Disease 691
Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age-sex interaction and spatial-temporal variability 679
Pain in focal dystonias - A focused review to address an important component of the disease 671
Whole-exome sequencing for variant discovery in blepharospasm 662
The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes 662
Global Fractional Anisotropy: Effect on Resting-state Neural Activity and Brain Networking in Healthy Participants 659
Early juvenile reading epilepsy and later frontotemporal dementia (FTD): expanding the clinical phenotype of C9ORF72 mutation? 658
Neurological phenomenology of the IRF2BPL mutation syndrome: Analysis of a new case and systematic review of the literature 641
Functional gait disorders: Demographic and clinical correlations 631
The mid-term effects of carotid endarterectomy on cognition and regional neural activity analyzed with the amplitude of low frequency fluctuations technique 624
Estimated EEG functional connectivity and aperiodic component induced by vagal nerve stimulation in patients with drug-resistant epilepsy 619
Incidence and spatial distribution of adult-onset primary malignant and other central nervous system tumors in Southern Sardinia, Italy 612
Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications 611
Olfactory hallucinations in Parkinson’s disease patients and the role of their evaluation in clinical practice. 605
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non‑tremor‑dominant subtypes really uncorrelated to olfactory impairment? 603
Functional neurological disorders as seen by a cohort of general practitioners in northern italy: Evidence from an online survey 602
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 568
A neural network-based software to recognise blepharospasm symptoms and to measure eye closure time 562
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease 556
Effect of botulinum toxin on non-motor symptoms in cervical dystonia 556
The Italian Dystonia Registry: rationale, design and preliminary findings 548
Cocaine-induced Pisa syndrome 545
Severity of REM sleep without atonia correlates with measures of cognitive impairment and depressive symptoms in REM sleep behaviour disorder 537
Blepharospasm 40 years later 536
Smoking and age-at-onset of both motor and non-motor symptoms in Parkinson's disease 533
Involuntary Thumb Flexion on Neurological Examination: An Unusual Form of Upper Limb Dystonia in the Faroe Islands 529
The association between white matter hyperintensities, cognition and regional neural activity in healthy subjects 522
Does epilepsy contribute to the clinical phenotype of C9orf72 mutation in fronto-temporal dementia? 517
Totale 146.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 301.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 301.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117.657 0 0 0 0 0 4.812 2.784 2.738 1.134 2.441 2.348 1.400
2021/202212.330 1.238 1.000 644 773 987 875 983 744 940 1.152 1.389 1.605
2022/202319.596 1.827 2.335 2.144 1.487 1.453 1.613 1.089 2.658 1.171 1.325 1.535 959
2023/202425.018 1.230 906 1.098 2.041 2.370 3.627 4.003 1.727 1.174 1.800 2.619 2.423
2024/202563.650 16.422 11.979 13.964 7.540 3.018 3.629 4.114 268 840 912 403 561
2025/20267.154 1.149 434 1.871 1.923 915 862 0 0 0 0 0 0
Totale 196.059